Miyake M, et al. – The physicians conducted this work to determine the combined use of the overactive bladder symptom score (OABSS) and International Prostate Symptom Score (IPSS) as an assessment tool for urinary symptom flare after iodine–125 (125I) implant brachytherapy. The evidence suggested that persistent lower urinary tract symptoms after seed implantation were attributed to storage rather than to voiding issues. They believe that assessment with the overactive bladder symptom score combined with the IPSS would aid in decision–making in terms of timing, selection of a treatment intervention, and assessment of the outcome.